生理学的輸送力は,ステントベースの配送のための薬物配布を統制する
1Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. cwhwang@mit.edu
Circulation
|August 2, 2001
まとめ
ステントからの薬物投与は,濃度グラデーションによる変動的な成功を示しています. 水性薬はインティマの近くで濃度が高くなり,ステントの配置は水性薬の配分に影響を与え,治療結果に影響を与えます.
科学分野:
- ファルマコキネティクスと薬物投与
- バイオメディカルエンジニアリング
- 心血管科学の研究について
背景:
- 早期のステントベースの薬物投与 (例えばヘパリン) は,有望な臨床前データにもかかわらず,臨床的に失敗しました.
- 最近の防水剤 (パクリタキセルなど) は,より高い有効性を示しており,特性による差異の調査を促しています.
研究 の 目的:
- 輸送力とステントの幾何学がステントを通じて投与される水性性および水性恐怖薬の分布にどのように影響するか調査する.
- 物理化学的性質の影響を理解し,ステントベースの配送における薬剤の有効性へのターゲティング.
主な方法:
- 薬物の分布をモデル化するために連続体薬動学の適用.
- 薬物の特性 (水性対水性) と輸送力 (ペクレットの数) に基づく濃度グラデーションと変動の分析.
- 不均質なステントストラット配置の影響の評価.
主要な成果:
- ステントの配送は,マイクロメートルにわたって大きく変化する重要な薬剤濃度グラデーションを生み出します.
- 水性薬は,水性薬と比較して,平均濃度が高く,インティマに局所化が良くなりました.
- 不均質なステント配置は,ヒドロフィール薬剤濃度よりもヒドロホビック薬剤濃度に悪影響を及ぼしました.
結論:
- 局所的な薬剤濃度とグラデーションは,単に近接性ではなく,生物学的効果にとって重要である.
- 生理学的輸送力は,平均濃度から著しい偏差を引き起こし,効果的なターゲティングに挑戦します.
- これらの薬動力学原理を理解することは,ステントベースの薬剤投与を最適化し,変数の臨床成功を説明するために不可欠です.
関連する概念動画
Drug Distribution: Volume of Distribution
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


